Antibodies against ganglioside complexes in Guillain-Barré syndrome and related disorders

Journal of Neurochemistry

Volumn 116, Issue 5, 2011, Pages 828-832

  Kusunoki, Susumu ^a   Kaida, Ken Ichi ^b  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

ganglioside; Guillain Barr syndrome; membrane microdomain; peripheral nerve

Indexed keywords

GANGLIOSIDE ANTIBODY; GANGLIOSIDE GD 1A; GANGLIOSIDE GD 1A ANTIBODY; GANGLIOSIDE GD 1B; GANGLIOSIDE GD 1B ANTIBODY; GANGLIOSIDE GM1; GANGLIOSIDE GM1 ANTIBODY; GANGLIOSIDE GQ 1B; GANGLIOSIDE GQ 1B ANTIBODY; GANGLIOSIDE GT 1B; GANGLIOSIDE GT 1B ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY PRODUCTION; ANTIBODY TITER; ANTIGEN BINDING; ARTIFICIAL VENTILATION; AUTOIMMUNE DISEASE; CELL MEMBRANE; COMPLEX FORMATION; CONFORMATIONAL TRANSITION; FLACCID PARALYSIS; GUILLAIN BARRE SYNDROME; HUMAN; IMMUNOASSAY; IMMUNOREACTIVITY; LIPID RAFT; NEUROPATHY; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

ANIMALS; ANTIBODIES; GANGLIOSIDES; GUILLAIN-BARRE SYNDROME; HUMANS; PERIPHERAL NERVOUS SYSTEM DISEASES;

EID: 79851471670     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2010.07029.x     Document Type: Review

References (24)

1. Capasso M., Caporale C. M., Pomilio F., Gandolfi P., Lugaresi A., and, Uncini A., (2003) Acute motor conduction block neuropathy: another Guillain-Barré syndrome variant. Neurology 61, 617-622. (Pubitemid 37082597)
2. Chiba A., Kusunoki S., Shimizu T., and, Kanazawa I., (1992) Serum IgG antibody to gangalioside GQ1b is a possible marker of Miller Fisher syndrome. Ann. Neurol. 31, 677-679.
3. Chiba A., Kusunoki S., Otaba H., Machinami R., and, Kanazawa I., (1993) Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies. Neurology 43, 1911-1917. (Pubitemid 23318855)
4. Greenshields K. N., Halstead S. K., Zitman F. M., et al. (2009) The neuropathic potential of anti-GM1 autoantibodies is required by the local glycolipid environment in mice. J. Clin. Invest. 119, 595-610.
5. Hadden R. D. M., Cornblath D. R., Hughes R. A., Zielasek J., Hartung H. P., Toyka K. V., and, Swan A. V., (1998) Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome: Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group. Ann. Neurol. 44, 780-788. (Pubitemid 28516049)
6. Hakomori S., (2002) The glycosynapse. Proc. Natl Acad. Sci. USA 99, 225-232. (Pubitemid 34060345)
7. Ho T. W., Mishu B., Li C. Y., Gao C. Y., Cornblath D. R., Griffin J. W., Asbury A. K., Blaser M. J., and, McKhann G. M., (1995) Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain 118, 597-605.
8. Kaida K., Kusunoki S., Kamakura K., Motoyoshi K., and, Kanazawa I., (2000) Guillain-Barré syndrome with antibody to a ganglioside, N-acetylgalactosaminyl GD1a. Brain 123, 116-124. (Pubitemid 30037974)
9. Kaida K., Morita D., Kanzaki M., Kamakura K., Motoyoshi K., Hirakawa M., and, Kusunoki S., (2004) Ganglioside complexes as new target antigens in Guillain-Barré syndrome. Ann. Neurol. 56, 567-571. (Pubitemid 39319349)
10. Kaida K., Kanzaki M., Morita D., Kamakura K., Motoyoshi K., Hirakawa M., and, Kusunoki S., (2006) Anti-ganglioside complex antibodies in Miller Fisher syndrome. J. Neurol. Neurosurg. Psychiatry 77, 1043-1046. (Pubitemid 44338527)
11. Kaida K., Morita D., Kanzaki M., Kamakura K., Motoyoshi K., Hirakawa M., and, Kusunoki S., (2007) Anti-ganglioside complex antibodies associated with severe disability in GBS. J. Neuroimmunol. 182, 212-218. (Pubitemid 46026709)
12. Kaida K., Sonoo M., Ogawa G., Kamakura K., Ueda-Sada M., Arita M., Motoyoshi K., and, Kusunoki S., (2008a) GM1/GalNAc-GD1a complex: a target for pure motor Guillain-Barré syndrome. Neurology 71, 1683-1690.
13. Kaida K., Kamakura K., Ogawa G., Ueda M., Motoyoshi K., Arita M., and, Kusunoki S., (2008b) GD1b-specific antibody induces ataxia in Guillain-Barré syndrome. Neurology 71, 196-201.
14. Kanzaki M., Kaida K., Ueda M., Morita D., Hirakawa M., Motoyoshi K., Kamakura K., and, Kusunoki S., (2008) Ganglioside complexes containing GQ1b as targets in Miller Fisher and Guillain-Barré syndrome. J. Neurol. Neurosurg. Psychiatry 79, 1148-1152.
15. Kuijf M. L., Godschalk P. C., Gilbert M., Endtz H. P., Tio-Gillen A. P., Ang C. W., van Doorn P. A., and, Jacobs B. C., (2007) Origin of ganglioside complex antibodies in Guillain-Barré syndrome. J. Neuroimmunol. 188, 69-73. (Pubitemid 47095018)
16. Kusunoki S., Shimizu J., Chiba A., Ugawa Y., Hitoshi S., and, Kanazawa I., (1996) Experimental sensory neuropathy induced by sensitization with ganglioside GD1b. Ann. Neurol. 39, 424-431. (Pubitemid 26117997)
17. Kusunoki S., Chiba A., and, Kanazawa I., (1999) Anti-GQ1b IgG antibody is associated with ataxia as well as ophthalmoplegia. Muscle Nerve 22, 1071-1074. (Pubitemid 29360252)
18. Kusunoki S., Kaida K., and, Ueda M., (2008) Antibodies against gangliosides and ganglioside complexes in Guillain-Barré syndrome: new aspects of research. Biochim. Biophys. Acta 1780, 441-444. (Pubitemid 351381251)
19. Liu J.-X., Willison H. J., and, Pedrosa-Domellof F., (2009) Immunolocalization of GQ1b and related gangliosides in human extraocular neuromuscular junctions and muscle spindles. Invest. Ophthalmol. Vis. Sci. 50, 3226-3232.
20. Nobile-Orazio E., Giannotta C., and, Briani C., (2010) Anti-ganglioside complex IgM antibodies in multifocal motor neuropathy and chronic immune-mediated neuropathies. J. Neuroimmunol. 219, 119-122.
21. Ogawa G., Kaida K., Kusunoki S., Ueda M., Kimura F., and, Kamakura K., (2009) Antibodies to ganglioside complexes consisting of asialo-GM1 and GQ1b or GT1a in Fisher and Guillain-Barré syndromes. J. Neuroimmunol. 214, 125-127.
22. Simons K., and, Ikonen E., (1997) Functional rafts in cell membranes. Nature 387, 569-572. (Pubitemid 27248754)
23. Van Doorn P., Ruts L., and, Jacobs B., (2008) Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome. Lancet Neurol. 7, 939-950.
24. Willison H. J., and, Yuki N., (2002) Peripheral neuropathies and anti-glycolipid antibodies. Brain 125, 2591-2625. (Pubitemid 35423511)